FreshRecalls

⚠ Data freshness notice: the most recent refresh of NHTSA was incomplete, so a very recent recall may be missing. Everything shown is accurate as of the last checked time on this page — for anything time-critical, confirm with the official sources linked below.

FDAClass II · Drug · Recalled June 24, 2026

Chlorthalidone Tablets recall — Inventia Healthcare Limited

Hazard: Failed Dissolution Specifications

Class II: may cause temporary or medically reversible health consequences.

View the official FDA enforcement record (openFDA) ↗

Official recall ID
D-0610-2026
Brand
Inventia Healthcare
Classification
Class II
Units affected
11,460 bottles
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Description

Chlorthalidone Tablets, USP, 25 mg, [100 or 1000] Tablets pr bottle, Rx only, Manufactured by: Inventia Healthcare Limited, Additional Ambernath, M.I.D.C., Ambernath (East) - 421506, INDIA. Distributed by: Risiong Pharma Holdings, Inc., East Brunswick, NJ 08816. NDC 100-tablet bottle: 64980-599-01; NDC 1000-tablet bottle: 64980-599-10

Affected products

Companies & origin

Recalling firm location
Kalyan, India
Firm address
Additional Ambernath Midc, Ambernath East; F1-F1/1-F75/1, N/A

Identifying details (verbatim from the notice)

Product codes / lots
[100 tablet bottle] Batch RISA24001; [1000 tablet bottle] Batch RISB24002; Exp. 04/2027
Distribution
U.S. Nationwide.
Firm notified the public via
Letter
FDA event ID
99136
Recall initiated
June 5, 2026
FDA classified
June 22, 2026
FDA report date
June 24, 2026

Source: U.S. Food & Drug Administration. This page mirrors the official public-domain record verbatim; the linked government source is authoritative. Source last checked July 23, 2026 at 11:04 PM UTC.

Report a data error on this page